Non-Opioid Pain Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 65 pages | ID: N12D162441ADEN
Market Monitor Global

Abstracts

Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals.

This report contains market size and forecasts of Non-Opioid Pain Treatment in Global, including the following market information:

Global Non-Opioid Pain Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Non-Opioid Pain Treatment market was valued at 20110 million in 2021 and is projected to reach US$ 54590 million by 2028, at a CAGR of 15.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medical Cannabis Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non-Opioid Pain Treatment include Allergan PLC, Canopy Growth, Medical Marijuana Inc., Panag Pharma Inc., Tilray, Aphria Inc., Bedrocan, Cara Therapeutics and Centrexion Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Opioid Pain Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-Opioid Pain Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Non-Opioid Pain Treatment Market Segment Percentages, by Type, 2021 (%)

• Medical Cannabis Treatment
• Capsaicin-derived Treatment
• Menthol-containing Treatment
• Omega 3 fatty acid-containing Treatment
• Botulinum Toxins

Global Non-Opioid Pain Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Non-Opioid Pain Treatment Market Segment Percentages, by Application, 2021 (%)

• Orthopaedic and Musculoskeletal Pain
• Neuropathic Pain
• Cancer Pain
• Others

Global Non-Opioid Pain Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Non-Opioid Pain Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non-Opioid Pain Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Non-Opioid Pain Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan PLC
• Canopy Growth
• Medical Marijuana Inc.
• Panag Pharma Inc.
• Tilray
• Aphria Inc.
• Bedrocan
• Cara Therapeutics
• Centrexion Therapeutics
• CHT Medical
• Cronos Group
• GW Pharmaceuticals
• Medropharm Gmbh
• US Worldmeds LLC

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Non-Opioid Pain Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Non-Opioid Pain Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NON-OPIOID PAIN TREATMENT OVERALL MARKET SIZE

2.1 Global Non-Opioid Pain Treatment Market Size: 2021 VS 2028
2.2 Global Non-Opioid Pain Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Non-Opioid Pain Treatment Players in Global Market
3.2 Top Global Non-Opioid Pain Treatment Companies Ranked by Revenue
3.3 Global Non-Opioid Pain Treatment Revenue by Companies
3.4 Top 3 and Top 5 Non-Opioid Pain Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non-Opioid Pain Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Opioid Pain Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Non-Opioid Pain Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Non-Opioid Pain Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Non-Opioid Pain Treatment Market Size Markets, 2021 & 2028
  4.1.2 Medical Cannabis Treatment
  4.1.3 Capsaicin-derived Treatment
  4.1.4 Menthol-containing Treatment
  4.1.5 Omega 3 fatty acid-containing Treatment
  4.1.6 Botulinum Toxins
4.2 By Type - Global Non-Opioid Pain Treatment Revenue & Forecasts
  4.2.1 By Type - Global Non-Opioid Pain Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Non-Opioid Pain Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Non-Opioid Pain Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Non-Opioid Pain Treatment Market Size, 2021 & 2028
  5.1.2 Orthopaedic and Musculoskeletal Pain
  5.1.3 Neuropathic Pain
  5.1.4 Cancer Pain
  5.1.5 Others
5.2 By Application - Global Non-Opioid Pain Treatment Revenue & Forecasts
  5.2.1 By Application - Global Non-Opioid Pain Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Non-Opioid Pain Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Non-Opioid Pain Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Non-Opioid Pain Treatment Market Size, 2021 & 2028
6.2 By Region - Global Non-Opioid Pain Treatment Revenue & Forecasts
  6.2.1 By Region - Global Non-Opioid Pain Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Non-Opioid Pain Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Non-Opioid Pain Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Non-Opioid Pain Treatment Revenue, 2017-2028
  6.3.2 US Non-Opioid Pain Treatment Market Size, 2017-2028
  6.3.3 Canada Non-Opioid Pain Treatment Market Size, 2017-2028
  6.3.4 Mexico Non-Opioid Pain Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Non-Opioid Pain Treatment Revenue, 2017-2028
  6.4.2 Germany Non-Opioid Pain Treatment Market Size, 2017-2028
  6.4.3 France Non-Opioid Pain Treatment Market Size, 2017-2028
  6.4.4 U.K. Non-Opioid Pain Treatment Market Size, 2017-2028
  6.4.5 Italy Non-Opioid Pain Treatment Market Size, 2017-2028
  6.4.6 Russia Non-Opioid Pain Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Non-Opioid Pain Treatment Market Size, 2017-2028
  6.4.8 Benelux Non-Opioid Pain Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Non-Opioid Pain Treatment Revenue, 2017-2028
  6.5.2 China Non-Opioid Pain Treatment Market Size, 2017-2028
  6.5.3 Japan Non-Opioid Pain Treatment Market Size, 2017-2028
  6.5.4 South Korea Non-Opioid Pain Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Non-Opioid Pain Treatment Market Size, 2017-2028
  6.5.6 India Non-Opioid Pain Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Non-Opioid Pain Treatment Revenue, 2017-2028
  6.6.2 Brazil Non-Opioid Pain Treatment Market Size, 2017-2028
  6.6.3 Argentina Non-Opioid Pain Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Non-Opioid Pain Treatment Revenue, 2017-2028
  6.7.2 Turkey Non-Opioid Pain Treatment Market Size, 2017-2028
  6.7.3 Israel Non-Opioid Pain Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Non-Opioid Pain Treatment Market Size, 2017-2028
  6.7.5 UAE Non-Opioid Pain Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan PLC
  7.1.1 Allergan PLC Corporate Summary
  7.1.2 Allergan PLC Business Overview
  7.1.3 Allergan PLC Non-Opioid Pain Treatment Major Product Offerings
  7.1.4 Allergan PLC Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.1.5 Allergan PLC Key News
7.2 Canopy Growth
  7.2.1 Canopy Growth Corporate Summary
  7.2.2 Canopy Growth Business Overview
  7.2.3 Canopy Growth Non-Opioid Pain Treatment Major Product Offerings
  7.2.4 Canopy Growth Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.2.5 Canopy Growth Key News
7.3 Medical Marijuana Inc.
  7.3.1 Medical Marijuana Inc. Corporate Summary
  7.3.2 Medical Marijuana Inc. Business Overview
  7.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Major Product Offerings
  7.3.4 Medical Marijuana Inc. Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.3.5 Medical Marijuana Inc. Key News
7.4 Panag Pharma Inc.
  7.4.1 Panag Pharma Inc. Corporate Summary
  7.4.2 Panag Pharma Inc. Business Overview
  7.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Major Product Offerings
  7.4.4 Panag Pharma Inc. Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.4.5 Panag Pharma Inc. Key News
7.5 Tilray
  7.5.1 Tilray Corporate Summary
  7.5.2 Tilray Business Overview
  7.5.3 Tilray Non-Opioid Pain Treatment Major Product Offerings
  7.5.4 Tilray Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.5.5 Tilray Key News
7.6 Aphria Inc.
  7.6.1 Aphria Inc. Corporate Summary
  7.6.2 Aphria Inc. Business Overview
  7.6.3 Aphria Inc. Non-Opioid Pain Treatment Major Product Offerings
  7.6.4 Aphria Inc. Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.6.5 Aphria Inc. Key News
7.7 Bedrocan
  7.7.1 Bedrocan Corporate Summary
  7.7.2 Bedrocan Business Overview
  7.7.3 Bedrocan Non-Opioid Pain Treatment Major Product Offerings
  7.7.4 Bedrocan Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.7.5 Bedrocan Key News
7.8 Cara Therapeutics
  7.8.1 Cara Therapeutics Corporate Summary
  7.8.2 Cara Therapeutics Business Overview
  7.8.3 Cara Therapeutics Non-Opioid Pain Treatment Major Product Offerings
  7.8.4 Cara Therapeutics Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.8.5 Cara Therapeutics Key News
7.9 Centrexion Therapeutics
  7.9.1 Centrexion Therapeutics Corporate Summary
  7.9.2 Centrexion Therapeutics Business Overview
  7.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Major Product Offerings
  7.9.4 Centrexion Therapeutics Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.9.5 Centrexion Therapeutics Key News
7.10 CHT Medical
  7.10.1 CHT Medical Corporate Summary
  7.10.2 CHT Medical Business Overview
  7.10.3 CHT Medical Non-Opioid Pain Treatment Major Product Offerings
  7.10.4 CHT Medical Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.10.5 CHT Medical Key News
7.11 Cronos Group
  7.11.1 Cronos Group Corporate Summary
  7.11.2 Cronos Group Business Overview
  7.11.3 Cronos Group Non-Opioid Pain Treatment Major Product Offerings
  7.11.4 Cronos Group Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.11.5 Cronos Group Key News
7.12 GW Pharmaceuticals
  7.12.1 GW Pharmaceuticals Corporate Summary
  7.12.2 GW Pharmaceuticals Business Overview
  7.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Major Product Offerings
  7.12.4 GW Pharmaceuticals Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.12.5 GW Pharmaceuticals Key News
7.13 Medropharm Gmbh
  7.13.1 Medropharm Gmbh Corporate Summary
  7.13.2 Medropharm Gmbh Business Overview
  7.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Major Product Offerings
  7.13.4 Medropharm Gmbh Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.13.5 Medropharm Gmbh Key News
7.14 US Worldmeds LLC
  7.14.1 US Worldmeds LLC Corporate Summary
  7.14.2 US Worldmeds LLC Business Overview
  7.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Major Product Offerings
  7.14.4 US Worldmeds LLC Non-Opioid Pain Treatment Revenue in Global Market (2017-2022)
  7.14.5 US Worldmeds LLC Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Non-Opioid Pain Treatment Market Opportunities & Trends in Global Market
Table 2. Non-Opioid Pain Treatment Market Drivers in Global Market
Table 3. Non-Opioid Pain Treatment Market Restraints in Global Market
Table 4. Key Players of Non-Opioid Pain Treatment in Global Market
Table 5. Top Non-Opioid Pain Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non-Opioid Pain Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non-Opioid Pain Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non-Opioid Pain Treatment Product Type
Table 9. List of Global Tier 1 Non-Opioid Pain Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Opioid Pain Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non-Opioid Pain Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non-Opioid Pain Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non-Opioid Pain Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Non-Opioid Pain Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non-Opioid Pain Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non-Opioid Pain Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Non-Opioid Pain Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non-Opioid Pain Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non-Opioid Pain Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non-Opioid Pain Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non-Opioid Pain Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non-Opioid Pain Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non-Opioid Pain Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non-Opioid Pain Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Allergan PLC Corporate Summary
Table 31. Allergan PLC Non-Opioid Pain Treatment Product Offerings
Table 32. Allergan PLC Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Canopy Growth Corporate Summary
Table 34. Canopy Growth Non-Opioid Pain Treatment Product Offerings
Table 35. Canopy Growth Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Medical Marijuana Inc. Corporate Summary
Table 37. Medical Marijuana Inc. Non-Opioid Pain Treatment Product Offerings
Table 38. Medical Marijuana Inc. Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Panag Pharma Inc. Corporate Summary
Table 40. Panag Pharma Inc. Non-Opioid Pain Treatment Product Offerings
Table 41. Panag Pharma Inc. Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Tilray Corporate Summary
Table 43. Tilray Non-Opioid Pain Treatment Product Offerings
Table 44. Tilray Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Aphria Inc. Corporate Summary
Table 46. Aphria Inc. Non-Opioid Pain Treatment Product Offerings
Table 47. Aphria Inc. Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Bedrocan Corporate Summary
Table 49. Bedrocan Non-Opioid Pain Treatment Product Offerings
Table 50. Bedrocan Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Cara Therapeutics Corporate Summary
Table 52. Cara Therapeutics Non-Opioid Pain Treatment Product Offerings
Table 53. Cara Therapeutics Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Centrexion Therapeutics Corporate Summary
Table 55. Centrexion Therapeutics Non-Opioid Pain Treatment Product Offerings
Table 56. Centrexion Therapeutics Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 57. CHT Medical Corporate Summary
Table 58. CHT Medical Non-Opioid Pain Treatment Product Offerings
Table 59. CHT Medical Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Cronos Group Corporate Summary
Table 61. Cronos Group Non-Opioid Pain Treatment Product Offerings
Table 62. Cronos Group Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 63. GW Pharmaceuticals Corporate Summary
Table 64. GW Pharmaceuticals Non-Opioid Pain Treatment Product Offerings
Table 65. GW Pharmaceuticals Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Medropharm Gmbh Corporate Summary
Table 67. Medropharm Gmbh Non-Opioid Pain Treatment Product Offerings
Table 68. Medropharm Gmbh Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)
Table 69. US Worldmeds LLC Corporate Summary
Table 70. US Worldmeds LLC Non-Opioid Pain Treatment Product Offerings
Table 71. US Worldmeds LLC Non-Opioid Pain Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Non-Opioid Pain Treatment Segment by Type in 2021
Figure 2. Non-Opioid Pain Treatment Segment by Application in 2021
Figure 3. Global Non-Opioid Pain Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-Opioid Pain Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-Opioid Pain Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Opioid Pain Treatment Revenue in 2021
Figure 8. By Type - Global Non-Opioid Pain Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non-Opioid Pain Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non-Opioid Pain Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non-Opioid Pain Treatment Revenue Market Share, 2017-2028
Figure 12. US Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non-Opioid Pain Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non-Opioid Pain Treatment Revenue Market Share, 2017-2028
Figure 24. China Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non-Opioid Pain Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non-Opioid Pain Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non-Opioid Pain Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan PLC Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Canopy Growth Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Medical Marijuana Inc. Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Panag Pharma Inc. Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Tilray Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Aphria Inc. Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bedrocan Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cara Therapeutics Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Centrexion Therapeutics Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CHT Medical Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Cronos Group Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. GW Pharmaceuticals Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Medropharm Gmbh Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. US Worldmeds LLC Non-Opioid Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)